Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research

Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research
According to a new report Global Cardiac Biomarkers Testing Market, published by KBV research, The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.


The North America market dominated the Global Creatine Kinase (CK-MB) Market by Region in 2018, growing at a CAGR of 9.9 % during the forecast period. The Europe market is expected to witness a CAGR of 10.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 12% during (2019-2025).


The Myocardial Infarction market dominated the Global Cardiac Biomarkers Testing Market by Application in 2018, growing at a CAGR of 11 % during the forecast period. The Congestive Heart Failure market is expected to witness a CAGR of 12.5% during (2019-2025). Additionally, The Acute Coronary Syndrome market is expected to witness highest CAGR of 10.9% during (2019-2025).


The Laboratory Testing market dominated the Global Cardiac Biomarkers Testing Market by Location of Testing in 2018, growing at a CAGR of 10.3 % during the forecast period. The Point of Care Testing market is expected to witness highest CAGR of 13.6% during (2019-2025).


Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/


The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.


Global Cardiac Biomarkers Testing Market Segmentation


By Type


Creatine Kinase (CK-MB)


Troponins


Myoglobin


Natriuretic Peptides (BNP and NT-proBNP)


Ischemia Modified Albumin


Others


By Application


Myocardial Infarction


Congestive Heart Failure


Acute Coronary Syndrome


Atherosclerosis


Others


By Location of Testing


Point of Care Testing


Laboratory Testing


By Geography


North America


US


Canada


Mexico


Rest of North America


Europe


Germany


UK


France


Russia


Spain


Italy


Rest of Europe


Asia Pacific


China


Japan


India


South Korea


Singapore


Malaysia


Rest of Asia Pacific


LAMEA


Brazil


Argentina


UAE


Saudi Arabia


South Africa


Nigeria


Rest of LAMEA


Companies Profiled


Trivitron Healthcare Pvt. Ltd.


Abbott Laboratories


Siemens AG


Becton, Dickinson AND Company


Bio-Rad Laboratories, Inc.


Randox Laboratories Limited


Danaher Corporation


Thermo Fisher Scientific, Inc.


Johnson and Johnson


Quidel Corporation


Cardiac Biomarkers Testing Market Related Reports:


North America Market


Europe Market


Asia Pacific Market


LAMEA Market


 

FECHA: a las 12:57h (305 Lecturas)

TAGS: Cardiac Biomarkers, Cardiac Biomarkers Testing Market, KBV Research

EN: Bienestar